Skip to main content
. 2021 Aug 4;9(8):957. doi: 10.3390/biomedicines9080957

Figure 2.

Figure 2

Difference in flow-mediated dilation (FMD) between convalescent coronavirus disease 2019 (COVID-19) patients and controls stratified according to the number of vascular risk factors.